Credit Suisse’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $2.18M | Buy |
74,728
+1,853
| +3% | +$54.1K | ﹤0.01% | 1783 |
|
|
2023
Q4 | $2.46M | Buy |
72,875
+19,481
| +36% | +$657K | ﹤0.01% | 1756 |
|
|
2023
Q3 | $1.64M | Sell |
53,394
-2,455
| -4% | -$75.3K | ﹤0.01% | 1947 |
|
|
2023
Q2 | $2.24M | Buy |
55,849
+675
| +1% | +$27K | ﹤0.01% | 1820 |
|
|
2023
Q1 | $2.25M | Buy |
55,174
+1,019
| +2% | +$41.6K | ﹤0.01% | 1772 |
|
|
2022
Q4 | $2.09M | Buy |
54,155
+7,095
| +15% | +$274K | ﹤0.01% | 1829 |
|
|
2022
Q3 | $2.5M | Buy |
47,060
+1,678
| +4% | +$89.3K | ﹤0.01% | 1681 |
|
|
2022
Q2 | $2.65M | Sell |
45,382
-6,091
| -12% | -$355K | ﹤0.01% | 1703 |
|
|
2022
Q1 | $3.93M | Buy |
51,473
+6,750
| +15% | +$515K | ﹤0.01% | 1622 |
|
|
2021
Q4 | $2.69M | Sell |
44,723
-19,965
| -31% | -$1.2M | ﹤0.01% | 1950 |
|
|
2021
Q3 | $3.62M | Buy |
64,688
+13,044
| +25% | +$731K | ﹤0.01% | 1735 |
|
|
2021
Q2 | $3.14M | Buy |
51,644
+4,661
| +10% | +$283K | ﹤0.01% | 1867 |
|
|
2021
Q1 | $3.29M | Sell |
46,983
-20,993
| -31% | -$1.47M | ﹤0.01% | 1827 |
|
|
2020
Q4 | $4.07M | Buy |
67,976
+28,009
| +70% | +$1.68M | ﹤0.01% | 1668 |
|
|
2020
Q3 | $2.4M | Sell |
39,967
-33,392
| -46% | -$2.01M | ﹤0.01% | 1692 |
|
|
2020
Q2 | $3.85M | Sell |
73,359
-17,670
| -19% | -$927K | ﹤0.01% | 1444 |
|
|
2020
Q1 | $3.05M | Sell |
91,029
-7,458
| -8% | -$250K | ﹤0.01% | 1410 |
|
|
2019
Q4 | $4.46M | Buy |
98,487
+63,626
| +183% | +$2.88M | ﹤0.01% | 1483 |
|
|
2019
Q3 | $1.33M | Sell |
34,861
-42,281
| -55% | -$1.61M | ﹤0.01% | 2213 |
|
|
2019
Q2 | $3.36M | Sell |
77,142
-55,375
| -42% | -$2.41M | ﹤0.01% | 1605 |
|
|
2019
Q1 | $5.04M | Buy |
132,517
+95,778
| +261% | +$3.65M | ﹤0.01% | 1321 |
|
|
2018
Q4 | $1.58M | Sell |
36,739
-312
| -0.8% | -$13.4K | ﹤0.01% | 1960 |
|
|
2018
Q3 | $1.82M | Sell |
37,051
-4,390
| -11% | -$216K | ﹤0.01% | 2007 |
|
|
2018
Q2 | $1.33M | Sell |
41,441
-3,457
| -8% | -$111K | ﹤0.01% | 2386 |
|
|
2018
Q1 | $1.4M | Sell |
44,898
-28,975
| -39% | -$903K | ﹤0.01% | 2340 |
|
|
2017
Q4 | $3.37M | Buy |
73,873
+30,310
| +70% | +$1.38M | ﹤0.01% | 1695 |
|
|
2017
Q3 | $1.64M | Buy |
43,563
+18,874
| +76% | +$709K | ﹤0.01% | 2294 |
|
|
2017
Q2 | $1.18M | Buy |
24,689
+2,311
| +10% | +$110K | ﹤0.01% | 2249 |
|
|
2017
Q1 | $1.02M | Sell |
22,378
-114,108
| -84% | -$5.2M | ﹤0.01% | 2505 |
|
|
2016
Q4 | $4.41M | Buy |
136,486
+71,417
| +110% | +$2.31M | ﹤0.01% | 1507 |
|
|
2016
Q3 | $2.23M | Sell |
65,069
-22,925
| -26% | -$784K | ﹤0.01% | 2016 |
|
|
2016
Q2 | $2.97M | Buy |
87,994
+57,788
| +191% | +$1.95M | ﹤0.01% | 1807 |
|
|
2016
Q1 | $1.6M | Sell |
30,206
-20,527
| -40% | -$1.09M | ﹤0.01% | 2124 |
|
|
2015
Q4 | $3.9M | Buy |
50,733
+11,305
| +29% | +$868K | ﹤0.01% | 1642 |
|
|
2015
Q3 | $1.62M | Sell |
39,428
-23,522
| -37% | -$967K | ﹤0.01% | 2240 |
|
|
2015
Q2 | $4.45M | Buy |
62,950
+33,031
| +110% | +$2.34M | ﹤0.01% | 1680 |
|
|
2015
Q1 | $2.66M | Sell |
29,919
-19,459
| -39% | -$1.73M | ﹤0.01% | 1943 |
|
|
2014
Q4 | $4.38M | Buy |
49,378
+15,482
| +46% | +$1.37M | ﹤0.01% | 1612 |
|
|
2014
Q3 | $3.29M | Buy |
33,896
+1,318
| +4% | +$128K | ﹤0.01% | 1799 |
|
|
2014
Q2 | $2.99M | Buy |
32,578
+8,984
| +38% | +$825K | ﹤0.01% | 2049 |
|
|
2014
Q1 | $1.65M | Sell |
23,594
-39,689
| -63% | -$2.78M | ﹤0.01% | 2360 |
|
|
2013
Q4 | $3.64M | Buy |
63,283
+31,303
| +98% | +$1.8M | ﹤0.01% | 1806 |
|
|
2013
Q3 | $1.54M | Buy |
31,980
+7,619
| +31% | +$366K | ﹤0.01% | 2254 |
|
|
2013
Q2 | $706K | Buy |
+24,361
| New | +$706K | ﹤0.01% | 2696 |
|